New hope for safer pain relief in vulnerable elderly cancer patients
NCT ID NCT07421674
Summary
This study is testing whether a specific long-acting pain medication (hydromorphone) is safe and effective for elderly cancer patients who also have reduced kidney function. Researchers will compare 62 patients with kidney problems to those with normal kidney function, monitoring pain relief, quality of life, and safety, especially regarding kidney health and side effects. The goal is to provide better, safer pain management options for this vulnerable group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY, CHRONIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tai'an Caner Hospital
Tai’an, Shandong, 271000, China
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.